Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Cipla
Johnson and Johnson
Teva
Medtronic
Harvard Business School
Covington
Healthtrust

Generated: June 19, 2018

DrugPatentWatch Database Preview

TRAL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Tral, and what generic alternatives are available?

Tral is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in TRAL is hexocyclium methylsulfate. Additional details are available on the hexocyclium methylsulfate profile page.
Summary for TRAL
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 13
Patent Applications: 424
DailyMed Link:TRAL at DailyMed
Drug patent expirations by year for TRAL
Synonyms for TRAL
1-cyclohexyl-2-(4,4-dimethylpiperazin-4-ium-1-yl)-1-phenylet
1-cyclohexyl-2-(4,4-dimethylpiperazin-4-ium-1-yl)-1-phenylethanol; methyl sulfate
1-cyclohexyl-2-(4,4-dimethylpiperazin-4-ium-1-yl)-1-phenylethanol;methyl sulfate
115-63-9
4-(.beta.-Cyclohexyl-.beta.-hydroxyphenethyl)-1,1-dimethylpiperazinium methyl sulfate
4-(2-cyclohexyl-2-hydroxy-2-phenylethyl)-1,1-dimethylpiperazin-1-ium methyl sulfate
4-(beta-Cyclohexyl-beta-hydroxyphenethyl)-1,1-dimethylpiperazinium methylsulfate
4-(beta-Cyclohexyl-beta-hydroxyphenethyl)-1,1-dimethylpiperazinum methylsulfate
6004-98-4 (Parent)
AB 803
AC1L2R4W
AC1Q41FA
AK398654
AKOS027382848
C20H33N2O.CH4O4S
CAS-115-63-9
CHEBI:5708
CHEMBL1626570
D01003
DSSTox_CID_3123
DSSTox_GSID_23123
DSSTox_RID_76883
DTXSID4023123
EINECS 204-097-2
HE068145
HE298609
Hexacyclium methyl sulfate
Hexocyclii metilsulfas
Hexocyclii metilsulfas [INN-Latin]
Hexocyclium (tral)
Hexocyclium (VAN)
Hexocyclium methosulfate
Hexocyclium methyl sulfate
Hexocyclium methylsulfate
Hexocyclium methylsulphate
Hexocyclium metilsulfate
Hexocyclium metilsulfate (INN)
Hexocycliummetilsulfat
HEXOCYCLUM METHYL SULFATE(1-)
LS-113656
Metilsulfate d'hexocyclium
Metilsulfate d'hexocyclium [INN-French]
Metilsulfato de hexociclo
Metilsulfato de hexociclo [INN-Spanish]
N-(beta-cyclohexyl-beta-hydroxy-beta-phenyl-ethyl)-n'-methylpiperazine methosulfate
N-(beta-Cyclohexyl-beta-hydroxy-beta-phenylethyl)-N'-methylpiperazine dimethylsulfate
NCGC00182972-01
NSC 30256
NSC-30256
NSC30256
Oxoamyl salicylate
Piperazinium, 4-(2-cyclohexyl-2-hydroxy-2-phenylethyl)-1,1-dimethyl-, methyl sulfate (salt)
Piperazinium, 4-(2-cyclohexyl-2-hydroxy-2-phenylethyl)-1,1-dimethyl-, methyl sulfate (salt) (9CI)
Piperazinium, 4-(beta-cyclohexyl-beta-hydroxyphenethyl)-1,1-dimethyl-, methyl sulfate
Piperazinium,1-dimethyl-, methyl sulfate
Piperazinium,1-dimethyl-, methyl sulfate (salt)
SCHEMBL25730
Tox21_113224
Tral (TN)
Traline
WLN: T6K DNTJ A1 A1 DXQ1R&- AL6TJ &WSQO1

US Patents and Regulatory Information for TRAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie TRAL hexocyclium methylsulfate TABLET;ORAL 010599-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Farmers Insurance
Cerilliant
Colorcon
Mallinckrodt
Teva
Harvard Business School
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.